“Group II Metabotropic and -Amino-3-hydroxy-5-methyl-4-isoxazole Propionate (AMPA)/Kainate Glutamate Receptors Regulate the Deficit in Brain Reward Function Associated with Nicotine Withdrawal in Rats,” The Journal Of Pharmacology And Experimental Therapeutics, Vol. 306, No. 3 [JPET 306:1068-1076, 2003].